7597-22-0 Usage
Uses
Used in Organic Synthesis:
2-Chloro-4,6-dimorpholin-4-yl-1,3,5-triazine is utilized as a chemical intermediate in the synthesis of various organic compounds. Its unique structure, which includes the triazine ring and morpholine substituents, offers potential for the creation of new molecules with diverse applications.
Due to the limited information available on the compound's properties and applications, further research is necessary to fully understand its potential uses in different industries. This may include exploring its reactivity, stability, and compatibility with other chemicals, as well as assessing any potential hazards associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 7597-22-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,5,9 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 7597-22:
(6*7)+(5*5)+(4*9)+(3*7)+(2*2)+(1*2)=130
130 % 10 = 0
So 7597-22-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H16ClN5O2/c12-9-13-10(16-1-5-18-6-2-16)15-11(14-9)17-3-7-19-8-4-17/h1-8H2
7597-22-0Relevant articles and documents
Discovery of ortho-carborane-conjugated triazines as selective topoisomerase I/II inhibitors
Nakamura, Hiroyuki,Shoji, Atsushi,Takeuchi, Ayano,Ban, Hyun Seung,Lee, Jong-Dae,Yamori, Takao,Kang, Sang Ook
scheme or table, p. 1430 - 1437 (2012/02/06)
The cell growth inhibition profile of 2,4-(2-methyl-ortho-carboranyl)-4- (dimethylamino)-1,3,5-triazine (TAZ-6) was found to be similar to that of ICRF-193, a topoisomerase II inhibitor, as revealed by COMPARE analysis (correlation coefficient (r)≤0.724). Various mono-and di-ortho-carborane- substituted 1,3,5-triazines were synthesized based on the structure of TAZ-6 and tested for their ability to inhibit cell growth and the activities of topoisomerases I and II. Among the compounds synthesized, 3c, 4c, and 4f completely inhibited topoisomerase I activity without affecting topoisomerase II activity, whereas 3a and 3d completely inhibited topoisomerase II activity without affecting topoisomerase I activity, at 100μM.